Feature | March 28, 2013

Women with Dense Breasts Welcome Additional Screening

Four different categories of breast density: fatty (top left), scattered fibroglandular (top right), heterogeneously dense (bottom left) and extremely dense (bottom right).

This image shows fatty breast density.

This image shows scattered fibroglandular breast density.

This image shows heterogeneously dense breast density.

This image shows extremely dense breast density.

December 11, 2012 — A survey of women undergoing routine screening mammography found that many of them would be interested in pursuing additional screening tests if notified they had dense breast tissue, despite the possibility of false positives, invasive procedures, and out-of-pocket costs, according to a clniical study presented at the annual meeting of the Radiological Society of North America (RSNA).

"Our study highlights the need for patient education regarding breast density," said Jafi Lipson, M.D., assistant professor of radiology at Stanford University School of Medicine in Stanford, Calif.

Recent studies have found that dense breast tissue is a strong independent risk factor for breast cancer. Breasts are composed of fat and fibroglandular tissue. Dense breast fibroglandular tissue appears white on a mammogram. Abnormalities and tumors also appear white on mammograms, causing them to be difficult to spot in dense breasts until the cancers are much larger and possibly in advanced stages.

"We hope this study raises awareness that dense breast tissue is a risk factor for breast cancer and that alternative technologies, including automated whole-breast ultrasound and contrast-enhanced mammography, are available to aid in screening women with dense breasts," said Haatal B. Dave, M.D., M.S., resident physician at Yale University School of Medicine in New Haven, Conn.

For the study, Lipson and Dave surveyed 105 women undergoing routine screening mammography at an outpatient radiology clinic. The women were asked if they knew their breast density and were informed about the association between higher breast density and increased risk of breast cancer. Women were then asked a set of questions about whether or not they would be interested in additional screening tests, such as automated whole-breast ultrasound or contrast-enhanced mammography, if they found out that they had dense breasts.

Of the 105 women surveyed, 76 percent were unaware of their breast density. Forty-two percent of the women had dense or extremely dense breast tissue. A majority of the surveyed women showed interest in the additional screening, despite the chance of increased false positives, invasive biopsy procedures and potential out-of-pocket expense.

Dave noted that educating the general public about the association between breast density and breast cancer risk is important, but that supplemental screenings are a matter of some debate in the medical and political realms. She added that many states do not require insurance companies to cover the cost for supplemental tests due to the lack of evidence of their mortality benefit.

Currently five states, including Connecticut, New York, Texas, California and Virginia, have passed bills that require radiologists to inform women of their breast density if they are found to have dense breast tissue. In 2011, a similar bill was introduced on a national level, and more than 10 other states have legislation pending.

Related Content

News | Biopsy Systems | August 25, 2016
August 25, 2016 — Dune Medical Devices has been selected as one of the few recipients of a European Union Horizon 202
Cigna, insurance coverage, 3-D mammography, breast cancer screening, Hologic
News | Mammography | August 25, 2016
August 25, 2016 — National insurer Cigna revised its medical coverage policy for breast cancer screening and will now
Fujifilm Aspire 3D mammography, tomosynthysis
News | August 25, 2016
August 25, 2016 — Fujifilm Medical Systems U.S.A. has submitted to the U.S.
Guided Therapeutics, LuViva Advanced Cerivcal Scan, first to Russia, cervical cancer
News | Oncology Diagnostics | August 24, 2016
August 24, 2016 — Guided Therapeutics Inc.
Alzheimer's, phase 3 study, MRI, LMTM, AAIC 2016
News | Neuro Imaging | August 24, 2016
Important clinical trial results in Alzheimer's disease and dementia were recently reported at the 2016 Alzheimer's...
Valiance X12, SPECT/CT, CZT detectors, clinical trial

Tc99m MDP SPECT bone study images of a 35 year old male with right ankle pain. Top: Valiance X12. Bottom: Analog SPECT. Image courtesy of Molecular Dynamics.

News | SPECT-CT | August 24, 2016
Molecular Dynamics has successfully completed the first phase of a clinical trial to evaluate the Valiance X12 whole-...
MRI, prostate cancer, zinc, UT Southwestern Medical Center study
News | Magnetic Resonance Imaging (MRI) | August 23, 2016
A novel magnetic resonance imaging (MRI) method that detects low levels of zinc ion can help distinguish healthy...
lung cancer, low-dose helical computed tomography, LDCT, Moffitt Cancer Center study, high-risk patients
News | Lung Cancer | August 22, 2016
August 22, 2016 — A new study found patients who tested negative for lung cancer by...
Fujifilm, Aspire Cristalle mammography system, Parascript AccuDetect, computer-aided detection software, Mena Regional Health System, Arkansas hospital

AccuDetect CAD software image courtesy of Parascript

News | Breast Imaging | August 22, 2016
Parascript announced that Mena Regional Health System (MRHS), Mena, Ark., has adopted Fujifilm’s Aspire Cristalle and...
News | Radiation Therapy | August 19, 2016
August 19, 2016 — Early-stage breast cancer patients receiving a shorter course of...
Overlay Init